Dynamic42 GmbH is a German biotechnology company developing human-relevant, immunocompetent organ-on-chip and microphysiological systems that replicate key aspects of human organ function. As a spin-off of Jena University Hospital, the company focuses on advancing preclinical research by providing more predictive, ethical alternatives to animal testing. Through its DynamicOrgan® platform, contract research services, and hands-on training, Dynamic42 enables scientists and industry partners to model diseases, test drugs and chemicals, and generate high-quality translational data that better reflects human biology.